BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27490645)

  • 1. Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.
    Dennis J; Truong V; Aïssi D; Medina-Rivera A; Blankenberg S; Germain M; Lemire M; Antounians L; Civelek M; Schnabel R; Wells P; Wilson MD; Morange PE; Trégouët DA; Gagnon F
    J Thromb Haemost; 2016 Oct; 14(10):1960-1970. PubMed ID: 27490645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels.
    Dennis J; Medina-Rivera A; Truong V; Antounians L; Zwingerman N; Carrasco G; Strug L; Wells P; Trégouët DA; Morange PE; Wilson MD; Gagnon F
    Genet Epidemiol; 2017 Jul; 41(5):455-466. PubMed ID: 28421636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A locus on chromosome 2 influences levels of tissue factor pathway inhibitor: results from the GAIT study.
    Almasy L; Soria JM; Souto JC; Warren DM; Buil A; Borrell M; Muñoz X; Sala N; Lathrop M; Fontcuberta J; Blangero J
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1489-92. PubMed ID: 15845911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms and plasma levels of tissue factor and tissue factor pathway inhibitor in venous thromboembolism.
    Kwon A; Jo SH; Jo YA; Park JY; Kim M; Kang HJ; Kim HS; Cho HC; Lee YK
    Blood Coagul Fibrinolysis; 2014 Jul; 25(5):416-21. PubMed ID: 24448154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide linkage scan in affected sibling pairs identifies novel susceptibility region for venous thromboembolism: Genetics In Familial Thrombosis study.
    de Visser MC; van Minkelen R; van Marion V; den Heijer M; Eikenboom J; Vos HL; Slagboom PE; Houwing-Duistermaat JJ; Rosendaal FR; Bertina RM
    J Thromb Haemost; 2013 Aug; 11(8):1474-84. PubMed ID: 23742623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes.
    Segers O; Simioni P; Tormene D; Castoldi E
    Thromb Haemost; 2014 Mar; 111(3):438-46. PubMed ID: 24226152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide linkage analysis for identifying quantitative trait loci involved in the regulation of lipoprotein a (Lpa) levels.
    López S; Buil A; Ordoñez J; Souto JC; Almasy L; Lathrop M; Blangero J; Blanco-Vaca F; Fontcuberta J; Soria JM
    Eur J Hum Genet; 2008 Nov; 16(11):1372-9. PubMed ID: 18560444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology.
    Zakai NA; Lutsey PL; Folsom AR; Heckbert SR; Cushman M
    Thromb Haemost; 2010 Aug; 104(2):207-12. PubMed ID: 20431849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of single nucleotide polymorphisms of tissue factor and tissue factor pathway inhibitor with venous thromboembolism in patients with lung cancer].
    Zhang XL; Zhu J; Chen WH; Zhai ZG; Zhang YH
    Zhonghua Yi Xue Za Zhi; 2018 Mar; 98(12):901-906. PubMed ID: 29665662
    [No Abstract]   [Full Text] [Related]  

  • 10. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
    Lincz LF; Adams MJ; Scorgie FE; Thom J; Baker RI; Seldon M
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):559-64. PubMed ID: 17762532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human tissue factor pathway inhibitor (TFPI) gene: complete genomic structure and localization on the genetic map of chromosome 2q.
    Enjyoji K; Emi M; Mukai T; Imada M; Leppert ML; Lalouel JM; Kato H
    Genomics; 1993 Aug; 17(2):423-8. PubMed ID: 8104873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism.
    Antoni G; Morange PE; Luo Y; Saut N; Burgos G; Heath S; Germain M; Biron-Andreani C; Schved JF; Pernod G; Galan P; Zelenika D; Alessi MC; Drouet L; Visvikis-Siest S; Wells PS; Lathrop M; Emmerich J; Tregouet DA; Gagnon F
    J Thromb Haemost; 2010 Dec; 8(12):2671-9. PubMed ID: 20946148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
    Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG
    Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotypes of TAFI gene and the risk of cerebral venous thrombosis--a case-control study.
    Orikaza CM; Morelli VM; Matos MF; Lourenço DM
    Thromb Res; 2014 Jan; 133(1):120-4. PubMed ID: 24252537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitized mutagenesis screen in Factor V Leiden mice identifies thrombosis suppressor loci.
    Westrick RJ; Tomberg K; Siebert AE; Zhu G; Winn ME; Dobies SL; Manning SL; Brake MA; Cleuren AC; Hobbs LM; Mishack LM; Johnston AJ; Kotnik E; Siemieniak DR; Xu J; Li JZ; Saunders TL; Ginsburg D
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9659-9664. PubMed ID: 28827327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage analysis identifies a novel locus for restless legs syndrome on chromosome 2q in a South Tyrolean population isolate.
    Pichler I; Marroni F; Volpato CB; Gusella JF; Klein C; Casari G; De Grandi A; Pramstaller PP
    Am J Hum Genet; 2006 Oct; 79(4):716-23. PubMed ID: 16960808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI.
    Erem C; Nuhoglu I; Kocak M; Yilmaz M; Sipahi ST; Ucuncu O; Ersoz HO
    Endocrine; 2008 Jun; 33(3):270-6. PubMed ID: 19016004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin generation as an intermediate phenotype for venous thrombosis.
    Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E
    Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations.
    Ameziane N; Seguin C; Borgel D; Fumeron F; Moatti D; Alhenc-Gelas M; Grandchamp B; Aiach M; Emmerich J; de Prost D
    Thromb Haemost; 2002 Aug; 88(2):195-9. PubMed ID: 12195688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant genetic association of a functional TFPI variant with circulating fibrinogen levels and coronary artery disease.
    Naji DH; Tan C; Han F; Zhao Y; Wang J; Wang D; Fa J; Li S; Chen S; Chen Q; Xu C; Wang QK
    Mol Genet Genomics; 2018 Feb; 293(1):119-128. PubMed ID: 28894953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.